275 related articles for article (PubMed ID: 33183344)
1. Fluctuation in anti-cyclic citrullinated protein antibody level predicts relapse from remission in rheumatoid arthritis: KURAMA cohort.
Murata K; Ito H; Hashimoto M; Murakami K; Watanabe R; Tanaka M; Yamamoto W; Matsuda S
Arthritis Res Ther; 2020 Nov; 22(1):268. PubMed ID: 33183344
[TBL] [Abstract][Full Text] [Related]
2. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
[TBL] [Abstract][Full Text] [Related]
3. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
4. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
[TBL] [Abstract][Full Text] [Related]
5. ACPA Antibodies Titer at the Time of Rheumatoid Arthritis Diagnosis Is Not Associated with Disease Severity.
Shpatz R; Braun-Moscovici Y; Balbir-Gurman A
Isr Med Assoc J; 2021 Oct; 23(10):646-650. PubMed ID: 34672447
[TBL] [Abstract][Full Text] [Related]
6. Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis.
Roos Ljungberg K; Börjesson E; Martinsson K; Wetterö J; Kastbom A; Svärd A
Arthritis Res Ther; 2020 Nov; 22(1):274. PubMed ID: 33225988
[TBL] [Abstract][Full Text] [Related]
7. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
Jonsson MK; Hensvold AH; Hansson M; Aga AB; Sexton J; Mathsson-Alm L; Cornillet M; Serre G; Lillegraven S; Fevang BS; Catrina AI; Haavardsholm EA
Arthritis Res Ther; 2018 Jul; 20(1):146. PubMed ID: 30001740
[TBL] [Abstract][Full Text] [Related]
8. Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis.
Manca ML; Alunno A; D'Amato C; Bistoni O; Puxeddu I; Gerli R; Migliorini P; Pratesi F
Joint Bone Spine; 2018 Jul; 85(4):441-445. PubMed ID: 28826660
[TBL] [Abstract][Full Text] [Related]
9. Is Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis Still a More Severe Disease Than Anti-Citrullinated Protein Antibody-Negative Rheumatoid Arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward.
Boer AC; Boonen A; van der Helm van Mil AHM
Arthritis Care Res (Hoboken); 2018 Jul; 70(7):987-996. PubMed ID: 29266813
[TBL] [Abstract][Full Text] [Related]
10. Association of cumulative anti-cyclic citrullinated protein antibodies with radiographic progression in patients with rheumatoid arthritis.
Joo YB; Park YJ; Park KS; Kim KJ
Clin Rheumatol; 2019 Sep; 38(9):2423-2432. PubMed ID: 31049760
[TBL] [Abstract][Full Text] [Related]
11. Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons.
Alivernini S; Galeazzi M; Peleg H; Tolusso B; Gremese E; Ferraccioli G; Naparstek Y
Autoimmun Rev; 2017 Nov; 16(11):1096-1102. PubMed ID: 28899798
[TBL] [Abstract][Full Text] [Related]
12. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis.
Reynisdottir G; Karimi R; Joshua V; Olsen H; Hensvold AH; Harju A; Engström M; Grunewald J; Nyren S; Eklund A; Klareskog L; Sköld CM; Catrina AI
Arthritis Rheumatol; 2014 Jan; 66(1):31-9. PubMed ID: 24449573
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.
Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Rönnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S
RMD Open; 2019; 5(2):e000946. PubMed ID: 31565241
[TBL] [Abstract][Full Text] [Related]
14. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.
Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J
J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777
[TBL] [Abstract][Full Text] [Related]
15. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.
Sahlström P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsström B; Stålesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmström V; Grönwall C
Arthritis Rheumatol; 2020 Oct; 72(10):1643-1657. PubMed ID: 32501655
[TBL] [Abstract][Full Text] [Related]
16. Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.
Katsumata M; Hozumi H; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T
Respir Med; 2019; 154():102-108. PubMed ID: 31229943
[TBL] [Abstract][Full Text] [Related]
17. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
[TBL] [Abstract][Full Text] [Related]
18. Association of Antibodies to Citrullinated Protein Antigens with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis.
Hughes-Austin JM; Gan RW; Deane KD; Weisman MH; Demoruelle MK; Sokolove J; Robinson WH; Holers VM; Norris JM; Ix JH
Am J Nephrol; 2017; 46(6):481-487. PubMed ID: 29237149
[TBL] [Abstract][Full Text] [Related]
19. Benefits of anticitrullinated peptides examination in rheumatoid arthritis.
Belakova G; Manka V; Zanova E; Racay P
Niger J Clin Pract; 2018 Oct; 21(10):1380-1383. PubMed ID: 30297575
[TBL] [Abstract][Full Text] [Related]
20. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
